Followers | 18 |
Posts | 6168 |
Boards Moderated | 3 |
Alias Born | 05/23/2019 |
Monday, July 25, 2022 1:09:26 PM
The Company transitioned from International Financial Reporting Standards (“IFRS”) to accounting principles generally accepted in the United States (“U.S. GAAP”). We are filing this Current Report on Form 8-K to amend our unaudited condensed consolidated interim financial statements for (i) the three months ended June 30, 2021, (ii) the three and six months ended September 30, 2021 and (iii) the three and nine months ended December 31, 2021 (collectively, the “FY2022 Interim Financial Statements”), to reflect the Company’s transition to U.S. GAAP. The original FY 2022 Interim Financial Statements were filed on Form 6-K on August 12, 2021, November 15, 2021 and February 10, 2022, respectively, under IFRS.
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001401395/58137be4-0c5c-4f40-8bc3-3236e8afea9d.pdf
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM